Risk of hospitalized depression and intentional self-harm with brand and authorized generic sertraline.

Autor: Pennap DD; U.S. Food and Drug Administration Center for Drug Evaluation and Research, Division of Epidemiology I, Silver Spring MD, United States. Electronic address: dinci.pennap@fda.hhs.gov., Swain RS; U.S. Food and Drug Administration Center for Drug Evaluation and Research, Division of Epidemiology I, Silver Spring MD, United States., Welch EC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston MA, United States., Bohn J; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston MA, United States., Lyons JG; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston MA, United States., Dutcher S; U.S. Food and Drug Administration Center for Drug Evaluation and Research, Regulatory Science Staff, Silver Spring MD, United States., Mosholder AD; U.S. Food and Drug Administration Center for Drug Evaluation and Research, Division of Epidemiology I, Silver Spring MD, United States.

Publikováno v: Journal of affective disorders [J Affect Disord] 2022 Jan 01; Vol. 296, pp. 635-641. Date of Electronic Publication: 2021 Oct 05.

Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study.

Autor: Zhao, Boya^1,2,3 (AUTHOR), Wu, Jing^1,3 (AUTHOR) jingwu@tju.edu.cn, Lu, Chengzhi⁴ (AUTHOR), Feng, Xing Lin² (AUTHOR) fxl@bjmu.edu.cn

Publikováno v: CTS: Clinical & Translational Science. Apr2024, Vol. 17 Issue 4, p1-12. 12p.

Impact and implications of national centralized drug procurement in China.

Autor: Wang Z; Department of Pharmacy, Xuanwu Hospital, The First Clinical Medical College of Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, China., Wang K; Department of Pharmacy, Xuanwu Hospital, The First Clinical Medical College of Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, China., Hua Y; Department of Pharmacy, Xuanwu Hospital, The First Clinical Medical College of Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, China., Dong X; Department of Pharmacy, Xuanwu Hospital, The First Clinical Medical College of Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, China., Zhang L; Department of Pharmacy, Xuanwu Hospital, The First Clinical Medical College of Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, China. xwzhanglan@126.com.

Publikováno v: International journal of clinical pharmacy [Int J Clin Pharm] 2024 Dec; Vol. 46 (6), pp. 1557-1562. Date of Electronic Publication: 2024 Jul 11.